{
  "nodes": [
    {
      "id": "N1",
      "label": "Step 1",
      "customData": {
        "node_id": "A",
        "node_step_index": 0,
        "content": "68-year-old Asian male with recurrent NSCLC and a 30-year history of psoriasis, previously treated with UVB phototherapy.",
        "clinical_data": {
          "diagnoses": [
            {
              "code": "C34",
              "label": "NSCLC",
              "status": "active"
            },
            {
              "code": "L40",
              "label": "psoriasis",
              "status": "historical"
            }
          ],
          "social_history": [
            {
              "category": "UVB phototherapy",
              "status": "past",
              "description": "30-year history of psoriasis, previously treated with UVB phototherapy."
            }
          ]
        }
      }
    },
    {
      "id": "N2",
      "label": "Step 2",
      "customData": {
        "node_id": "B",
        "node_step_index": 1,
        "content": "Patient presented with left upper lobe Stage IIB (pT3 (7.8cm) N0 (0/12)) adenocarcinoma at age 66.",
        "clinical_data": {
          "diagnoses": [
            {
              "code": "C34.3",
              "label": "Malignant neoplasm of lower lobe, bronchus or lung",
              "status": "active",
              "onset_date": null
            }
          ]
        }
      }
    },
    {
      "id": "N3",
      "label": "Step 3",
      "customData": {
        "node_id": "C",
        "node_step_index": 2,
        "content": "Patient underwent lobectomy and received four cycles of adjuvant cisplatin and vinorelbine at age 66.",
        "clinical_data": {
          "procedures": [
            {
              "name": "Lobectomy",
              "date": null
            }
          ],
          "medications": [
            {
              "drug": "cisplatin",
              "dosage": null,
              "frequency": null,
              "modality": null,
              "start_date": null,
              "end_date": null,
              "indication": "adjuvant"
            },
            {
              "drug": "vinorelbine",
              "dosage": null,
              "frequency": null,
              "modality": null,
              "start_date": null,
              "end_date": null,
              "indication": "adjuvant"
            }
          ]
        }
      }
    },
    {
      "id": "N4",
      "label": "Step 4",
      "customData": {
        "node_id": "D",
        "node_step_index": 3,
        "content": "Surveillance imaging one year after adjuvant chemotherapy showed multifocal ground glass nodules in lungs bilaterally with interval growth over multiple scans.",
        "clinical_data": {
          "imaging": [
            {
              "type": "Lung parenchyma CT",
              "body_part": "Lung",
              "modality": "CT",
              "finding": "multifocal ground glass nodules",
              "impression": "interval growth",
              "date": null
            }
          ]
        }
      }
    },
    {
      "id": "N5",
      "label": "Step 5",
      "customData": {
        "node_id": "E",
        "node_step_index": 4,
        "content": "Molecular characterization identified an epidermal growth factor receptor (EGFR) exon 19 deletion.",
        "clinical_data": {
          "diagnoses": [
            {
              "code": "C0597494",
              "label": "EGFR exon 19 deletion",
              "status": "active"
            }
          ]
        }
      }
    },
    {
      "id": "N6",
      "label": "Step 6",
      "customData": {
        "node_id": "F",
        "node_step_index": 5,
        "content": "Patient started on first-line osimertinib 80 mg daily one-and-half years after completion of adjuvant chemotherapy.",
        "clinical_data": {
          "medications": [
            {
              "drug": "C1705893",
              "dosage": "80 mg",
              "frequency": "daily",
              "modality": "oral",
              "start_date": null,
              "end_date": null,
              "indication": null
            }
          ]
        }
      }
    },
    {
      "id": "N7",
      "label": "Step 7",
      "customData": {
        "node_id": "G",
        "node_step_index": 6,
        "content": "Within two weeks of starting osimertinib, the patient had significant worsening of pre-existing scaly psoriatic plaques with desquamation over his face, trunk, upper and lower extremities, including inflammation of his fingertips with intermittent abdominal pain.",
        "clinical_data": {
          "medications": [
            {
              "drug": "C1608689",
              "start_date": null,
              "end_date": null,
              "indication": null
            }
          ],
          "HPI": [
            {
              "summary": "Significant worsening of pre-existing scaly psoriatic plaques with desquamation over face, trunk, upper and lower extremities, including inflammation of fingertips with intermittent abdominal pain within two weeks of starting osimertinib.",
              "duration": "2 weeks",
              "onset": null,
              "progression": "sudden",
              "associated_symptoms": [
                "C0000734",
                "C0036386",
                "C0000729"
              ],
              "alleviating_factors": [],
              "exacerbating_factors": []
            }
          ],
          "diagnoses": [
            {
              "code": "C0036386",
              "label": "Psoriasis",
              "status": "active",
              "onset_date": null
            }
          ]
        }
      }
    },
    {
      "id": "N8",
      "label": "Step 8",
      "customData": {
        "node_id": "H",
        "node_step_index": 7,
        "content": "Osimertinib was held, and Dermatology prescribed hydrocortisone cream and UVB phototherapy for psoriasis.",
        "clinical_data": {
          "medications": [
            {
              "drug": "C0020339",
              "dosage": null,
              "frequency": null,
              "modality": "topical",
              "start_date": null,
              "end_date": null,
              "indication": "C0036339"
            },
            {
              "drug": "C1607181",
              "dosage": null,
              "frequency": null,
              "modality": null,
              "start_date": null,
              "end_date": null,
              "indication": "C0007102"
            }
          ],
          "procedures": [
            {
              "name": "C0085139",
              "approach": null,
              "date": null,
              "location": null,
              "performed_by": "Dermatology",
              "outcome": null
            }
          ],
          "diagnoses": [
            {
              "code": "C0036339",
              "label": "Psoriasis",
              "status": "active",
              "onset_date": null
            }
          ]
        }
      }
    },
    {
      "id": "N9",
      "label": "Step 9",
      "customData": {
        "node_id": "I",
        "node_step_index": 8,
        "content": "Four weeks after osimertinib was held, the patient developed a temperature of 39.5\u00b0C with tachycardia and worsening abdominal pain and was admitted to hospital. Infection was ruled out. Skin toxicity was deemed psoriasis worsened by osimertinib potentially with associated dermatitis.",
        "clinical_data": {
          "vitals": [
            {
              "type": "Fever",
              "value": "39.5",
              "unit": "\u00b0C"
            },
            {
              "type": "Tachycardia",
              "value": null,
              "unit": null
            }
          ],
          "HPI": [
            {
              "summary": "Worsening abdominal pain",
              "progression": "worsening"
            }
          ],
          "diagnoses": [
            {
              "code": "P0000269",
              "label": "Psoriasis",
              "status": "active"
            },
            {
              "code": "D003844",
              "label": "Dermatitis",
              "status": "active"
            }
          ],
          "medications": [
            {
              "drug": "Osimertinib",
              "end_date": null,
              "indication": null
            }
          ]
        }
      }
    },
    {
      "id": "N10",
      "label": "Step 10",
      "customData": {
        "node_id": "J",
        "node_step_index": 9,
        "content": "Following hospital discharge, the patient commenced a 10-week course of UVB phototherapy, resulting in 90% clearance of skin lesions.",
        "clinical_data": {
          "procedures": [
            {
              "name": "Ultraviolet B Phototherapy",
              "date": null,
              "outcome": "90% clearance of skin lesions"
            }
          ]
        }
      }
    },
    {
      "id": "N11",
      "label": "Step 11",
      "customData": {
        "node_id": "K",
        "node_step_index": 10,
        "content": "Osimertinib was restarted at 40 mg daily, five months since his last dose, after completion of phototherapy.",
        "clinical_data": {
          "medications": [
            {
              "drug": "Osimertinib",
              "dosage": "40 mg",
              "frequency": "daily",
              "modality": "oral",
              "start_date": null,
              "end_date": null,
              "indication": null
            }
          ]
        }
      }
    },
    {
      "id": "N12",
      "label": "Step 12",
      "customData": {
        "node_id": "L",
        "node_step_index": 11,
        "content": "Within three days of restarting Osimertinib at 40 mg daily, the patient developed fever, tachycardia, widespread skin desquamation and swelling, particularly on arms and hands.",
        "clinical_data": {
          "medications": [
            {
              "drug": "C0884294",
              "dosage": "40 mg",
              "frequency": "daily",
              "modality": "oral",
              "start_date": null,
              "end_date": null,
              "indication": null
            }
          ],
          "HPI": [
            {
              "summary": "Patient developed fever, tachycardia, widespread skin desquamation and swelling, particularly on arms and hands within three days of restarting Osimertinib.",
              "duration": "P3D",
              "onset": null,
              "progression": "sudden",
              "associated_symptoms": [
                "C0015967",
                "C0039231",
                "C0262736",
                "C0039450"
              ],
              "alleviating_factors": [],
              "exacerbating_factors": []
            }
          ]
        }
      }
    },
    {
      "id": "N13",
      "label": "Step 13",
      "customData": {
        "node_id": "M",
        "node_step_index": 12,
        "content": "Patient had a WBC of 18.5 and CRP of 154. Infection was ruled out, and skin toxicity was deemed to be a severe toxic desquamating psoriatic skin reaction to osimertinib; however, the possibility of toxic epidermal necrolysis (TEN) was raised.",
        "clinical_data": {
          "labs": [
            {
              "test": "White blood cell count",
              "value": "18.5",
              "unit": "cells/mm3",
              "flag": "abnormal"
            },
            {
              "test": "C-Reactive Protein",
              "value": "154",
              "unit": "mg/L",
              "flag": "abnormal"
            }
          ],
          "diagnoses": [
            {
              "code": "SNOMED:23627002",
              "label": "Skin toxicity",
              "status": "active"
            },
            {
              "code": "SNOMED:255604002",
              "label": "Toxic epidermal necrolysis",
              "status": "suspected"
            }
          ],
          "allergies": [
            {
              "substance": "Osimertinib",
              "reaction": "Toxic desquamating psoriatic skin reaction",
              "severity": "severe"
            }
          ]
        }
      }
    },
    {
      "id": "N14",
      "label": "Step 14",
      "customData": {
        "node_id": "N",
        "node_step_index": 13,
        "content": "After recovery from skin toxicity, the patient started on carboplatin and pemetrexed.",
        "clinical_data": {
          "medications": [
            {
              "drug": "C0007127",
              "dosage": null,
              "frequency": null,
              "modality": null,
              "start_date": null,
              "end_date": null,
              "indication": null
            },
            {
              "drug": "C0976424",
              "dosage": null,
              "frequency": null,
              "modality": null,
              "start_date": null,
              "end_date": null,
              "indication": null
            }
          ]
        }
      }
    }
  ],
  "edges": [
    {
      "from": "N1",
      "to": "N2",
      "data": {
        "edge_id": "A_to_B",
        "branch_flag": true,
        "content": "Progression of NSCLC"
      }
    },
    {
      "from": "N2",
      "to": "N3",
      "data": {
        "edge_id": "B_to_C",
        "branch_flag": true,
        "content": "Treatment for Stage IIB NSCLC",
        "transition_event": {
          "trigger_type": "procedure",
          "trigger_entities": [
            "C0024090"
          ],
          "change_type": "addition",
          "target_domain": "procedure"
        }
      }
    },
    {
      "from": "N3",
      "to": "N4",
      "data": {
        "edge_id": "C_to_D",
        "branch_flag": true,
        "content": "Surveillance imaging post-treatment",
        "transition_event": {
          "trigger_type": "procedure",
          "trigger_entities": [
            "C0034864"
          ],
          "change_type": "addition",
          "target_domain": "imaging"
        }
      }
    },
    {
      "from": "N4",
      "to": "N5",
      "data": {
        "edge_id": "D_to_E",
        "branch_flag": true,
        "content": "Molecular characterization of NSCLC",
        "transition_event": {
          "trigger_type": "lab_change",
          "trigger_entities": [
            "C0597494"
          ],
          "change_type": "addition",
          "target_domain": "diagnosis"
        }
      }
    },
    {
      "from": "N5",
      "to": "N6",
      "data": {
        "edge_id": "E_to_F",
        "branch_flag": true,
        "content": "Initiation of first-line osimertinib",
        "transition_event": {
          "trigger_type": "medication_change",
          "trigger_entities": [
            "C1705893"
          ],
          "change_type": "addition",
          "target_domain": "medication"
        }
      }
    },
    {
      "from": "N6",
      "to": "N7",
      "data": {
        "edge_id": "F_to_G",
        "branch_flag": true,
        "content": "Worsening of psoriasis after starting osimertinib",
        "transition_event": {
          "trigger_type": "symptom_onset",
          "trigger_entities": [
            "C0036386",
            "C0000734",
            "C0000729"
          ],
          "change_type": "progression",
          "target_domain": "symptom"
        }
      }
    },
    {
      "from": "N7",
      "to": "N8",
      "data": {
        "edge_id": "G_to_H",
        "branch_flag": true,
        "content": "Osimertinib held, initiation of hydrocortisone and UVB phototherapy for psoriasis",
        "transition_event": {
          "trigger_type": "medication_change",
          "trigger_entities": [
            "C1705893",
            "C0020339",
            "C1607181"
          ],
          "change_type": "discontinuation",
          "target_domain": "medication"
        }
      }
    },
    {
      "from": "N8",
      "to": "N9",
      "data": {
        "edge_id": "H_to_I",
        "branch_flag": true,
        "content": "Development of fever, tachycardia, and worsening abdominal pain; hospitalization",
        "transition_event": {
          "trigger_type": "symptom_onset",
          "trigger_entities": [
            "C0015967",
            "C0039231",
            "C0000729"
          ],
          "change_type": "progression",
          "target_domain": "symptom"
        }
      }
    },
    {
      "from": "N9",
      "to": "N10",
      "data": {
        "edge_id": "I_to_J",
        "branch_flag": true,
        "content": "Commencement of UVB phototherapy after hospital discharge",
        "transition_event": {
          "trigger_type": "procedure",
          "trigger_entities": [
            "C0085139"
          ]
        }
      }
    }
  ]
}